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Supplementary Figure legends 
Figure S1. Maximum likelihood tree of nanA and nonA genes. Bootstrap values are shown 
near the nodes. Strains with identical DNA sequences are listed on the same branch. The scale 
bar indicates nucleotide substitutions per site. 
 
Figure S2. Schematic illustration of domain structures in streptococcal NanA, NanB, and 
NanC proteins. Strains with identical sequences are listed on the same branch. S. iniae NanA, S. 
pneumoniae NanB and NanC lack an LPXTG motif. 
 
Figure S3. Sialidase activities of bacterial cells and culture supernatants. A. The sialidase 
activities of GBS A909 and streptococcal type strains. B. The sialidase activities of GBS 
clinical strains and S. pneumoniae D39. C. The sialidase activities of clinically isolated S. iniae 
strains. The strains were isolates from brain of a diseased hybrid-stripedbass or tilapia at the 
Kent SeaTech aquaculture facility in Mecca, CA. After 2 h incubation at 37°C, fluorescence of 
degraded sialidase substrate was measured with excitation and emission wavelengths of 350 and 
460 nm, respectively. Data are presented as the mean of triplicate or sextuplet samples. S.E. 
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values are represented by vertical lines. The limit of sensitivity of the assay is 0.3 mU/mL. 
 
Figure S4. Maximum likelihood tree of nanA, nanB, nanC, and nonA genes. Bootstrap 
values are shown near nodes. The scale bar indicates nucleotide substitutions per site. 
 
Figure S5. Bayesian phylogenetic tree of nanA in S. pneumoniae. Percentage of posterior 
probabilities is shown near the nodes. The scale bar indicates nucleotide substitutions per site. 
FEL and FUBAR analyses were performed on nanA multiple alignment data and this tree. 
 
Figure S6. Bayesian phylogenetic tree of nonA in S. agalactiae. Percentage of posterior 
probabilities is shown near the nodes. The scale bar indicates nucleotide substitutions per site. 
FEL and FUBAR analyses were performed on nonA multiple alignment data and this tree. 
 
Figure S7. Bayesian phylogenetic tree of nanB in S. pneumoniae. Percentage of posterior 
probabilities is shown near the nodes. The scale bar indicates nucleotide substitutions per site. 
FEL and FUBAR analyses were performed on nanB multiple alignment data and this tree. 
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Figure S8. Bayesian phylogenetic tree of nanC in S. pneumoniae. Percentage of posterior 
probabilities is shown near the nodes. The scale bar indicates nucleotide substitutions per site. 
FEL and FUBAR analyses were performed on nanC multiple alignment data and this tree. 
 
Figure S9. Bayesian phylogenetic tree of bgaA in S. pneumoniae. Percentage of posterior 
probabilities is shown near the nodes. The scale bar indicates nucleotide substitutions per site. 
FEL and FUBAR analyses were performed on bgaA multiple alignment data and this tree. 
 
Figure S10. Bayesian phylogenetic tree of strH in S. pneumoniae. Percentage of posterior 
probabilities is shown near the nodes. The scale bar indicates nucleotide substitutions per site. 
FEL and FUBAR analyses were performed on strH multiple alignment data and this tree. 
 
Figure S11. Expression of nonA in GBS A909. The graph shows fold transcript level of cylE 
and nonA in GBS A909 wild type (filled bars) and !nonA mutant strain (open bars). RNA 
extractions were performed from mid-log phase cultures. The level of DNA gyrase subunit A 
gene (gyrA) transcription was used as an internal standard. The data represent the mean values 
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of triplicate samples. S.E. values are represented by vertical lines. 
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Table S1. Homology between NanA, NanB, and NanC of S. pneumoniae D39 and NonA of 
GBS A909 
 NanA NonA NanB NanC 
NanA - 49/58/75/1 63/25/43/17 53/27/44/16 
NonA 70/58/75/1 - 62/28/45/16 60/27/44/15 
NanB 88/25/43/17 62/28/45/16 - 94/51/69/0 
NanC 70/27/44/16 57/27/44/15 88/51/69/0 - 
Cover/Indentities/Positives/Gaps (%) 
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Table S2. Bacterial strains and the accession number of the genome sequences used for 
phylogenetic tree 
Bacteria Strain Accession number 
Streptococcus pneumoniae D39 CP000410.1 
 JJA CP000919.1 
 CGSP14 CP001033.1 
 Hungary19A-6 CP000936.1 
 ST556 CP003357.1 
 Taiwan19F-14 CP000921.1 
 SPNA45 CP000936.1 
 AP200 CP002121.1 
 G54 CP001015.1 
 gamPNI0373 CP001845.1 
 TCH8431/19A CP001993.1 
 ATCC700669 FM211187.1 
 P1031 CP000920.1 
 70585 CP000918.1 
 TIGR4 AE005672.3 
 670-6B CP002176.1 
 NT_110_58 CP007593.1 
Streptococcus agalactiae A909 CP000114.1 
 ILRI112 HF952106.1 
 GBS2-NM CP007571.1 
 GBS6 CP007572.1 
 GBS1-NY CP007570.1 
 SA20-06 CP003919.1 
 138spar CP007565.1 
 138P CP007482.1 
 2-22 FO393392.1 
 GD201008-001 CP003810.1 
 NEM316 AL766854.1 
 NGBS572 CP007632.1 
 2603V/R NC_004116.1 
 ILRI005 HF952105.1 
 CNCTC 10/84 CP006910.1 
 09mas018883 HF952104.1 
 NGBS061 CP007631.2 
 COH1 HG939456.1 
Streptococcus iniae ISNO CP007587.1 
 ISET0901 CP007586.1 
 YSFST01-82 CP010783.1 
 SF1 CP005941.1 
Streptococcus intermedius B196 CP003857.1 
 C270 CP003858.1 
 JTH08 AP010969.1 
Streptococcus mitis B6 FN568063.1 
 KCOM 1350 CP012646.1 
Streptococcus oralis Uo5 FR720602.1 
Streptococcus pseudopneumoniae IS7493 CP002925.1 
Streptococcus sp. VT 162 CP007628.2 
Erysipelothrix rhusiopathiae SY1027 AP012027.1 
 Fujisawa CP005079.1 
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Table S3. The frameshift mutation in GBS nonA genes. 
GBS strain DNA sequence (5’–3’) 
A909 T GAT TGG GGA AAC ATA GGA ATG GTT ATT CGC CGT AGT GA 
SA20-06 T GAT TGG GGG AAA CAT AGG AAT GGT TAT TCG CCG TAG TGA 
GX026 T GAT TGG GGG AAA CAT AGG AAT GGT TAT TCG CCG TAG TGA 
2-22 T GAT TGG GGG AAA CAT AGG AAT GGT TAT TCG CCG TAG TGA 
138spar T GAT TGG GGG AAA CAT AGG AAT GGT TAT TCG CCG TAG TGA 
138P T GAT TGG GGG AAA CAT AGG AAT GGT TAT TCG CCG TAG TGA 
Bold and underlined character is the inserted nucleotide. Box shows stop codons generated by 
the framshift. 
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Codons evolving under 
positive selection 
Codons evolving under 
negative selection 
nanA S. pneumoniae 16 0.29 0.940% (7/745) 15.302% (114/745) 
nonA S. agalactiae 16 0.35 0.885% (4/452) 1.770% (8/452) 
nanB S. pneumoniae 16 0.35 0.441% (2/454) 0.661% (3/454) 
nanC S. pneumoniae 6 0.29 0% (0/740) 2.703% (20/740) 
bgaA S. pneumoniae 14 0.29 0.806% (18/2233) 4.881% (109/2233) 
strH S. pneumoniae 17 0.50 0.758% (10/1319) 0.607% (8/1319) 
Evolutionary analysis was performed using Baysian inference of aligned nanA, nonA, nanB, 
nanC, bgaA, and strH sequences from S. pneumoniae or S. agalactiae, with FUBAR in the 
HyPhy software package. The dN/dS means ratio of non-synonymous changes to synonymous 
changes in overall analyzed genes. Individual codons with a statistically significant signature 
were also calculated and are expressed as a percentage of the total number of codons used in the 
analysis. 
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Table S5. Bacterial strains used in sialidase activity assay 
Bacteria Strain Remarks 
Streptococcus pneumoniae D39 Serotype 2 
Streptococcus agalactiae A909 Serotype Ia 
 M709 Serotype Ib 
 GBS2-NM Serotype II 
 GBS6 Serotype III 
 GBS1-NY Serotype V 
 SA20-06 Serotype VI 
Streptococcus mitis ATCC 49456/NCTC 12261/SK142 Type strain 
Streptococcus oralis ATCC 35037/NCTC 11427 Type strain 
Streptococcus pseudopneumoniae ATCC BAA-960/CCUG 49455/SK1069 Type strain 
Streptococcus intermedius ATCC 27335/SK54 Type strain 
Streptococcus iniae K122 Clinical strains 
 K139 Clinical strains 
 K277 Clinical strains 
 K288 Clinical strains 
 K375 Clinical strains 
 K436 Clinical strains 
 K540 Clinical strains 
 94-426 Clinical strains 
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Table S6. Real-time RT-PCR Primers used in this study 

















S. agalactiae strain COH1
S. agalactiae ILRI112
S. pneumoniae TCH8431/19A; ATCC 700669
S. agalactiae strain GBS6; GBS2-NM; GBS1-NY




S. mitis strain KCOM 1350
S. mitis B6
S. pneumoniae G54
Clostridium perfringens strain JP55
S. agalactiae A909; strain SG-M1; HN016; GD201008-001
S. intermedius B196
Erysipelothrix rhusiopathiae SY1027; str. Fujisawa
S. agalactiae strain 138spar; 138P; 2-22; strain GX026
S. pneumoniae ST556; Taiwan19F-14
S. agalactiae CNCTC 10/84
S. iniae strain YSFST01-82
S. pneumoniae D39; R6; OXC141
S. pneumoniae JJA
S. pneumoniae AP200
S. sp VT 162
S. pneumoniae Hungary19A-6
S. agalactiae strain H002; NGBS572; 2603V/R; NEM316
S. iniae strain ISNO; ISET0901; SF1




Clostridium perfringens str. 13
S. agalactiae strain SS1; NGBS061; 09mas018883
S. pneumoniae strain NT_110_58
S. pseudopneumoniae IS7493
Clostridium perfringens ATCC 13124
S. pneumoniae P1031
























S. oralis Uo5 
NanA, 1130 A.A.
S. intermedius B196 
NanA, 920 A.A.
S. iniae YSFST01-82 
NanA, 902 A.A.




LamG domain Sialidase domain LPXTG motif
LamG domain Sialidase domain LPXTG motif
LamG domain Sialidase domain LPXTG motif
LamG domain Sialidase domain LPXTG motif
LamG domain Sialidase domain
LamG domain Sialidase domain

















































































































































































































































































































































































S. agalactiae strain GBS85147
S. agalactiae strain COH1









S. agalactiae A909; strain SG-M1; HN016; GD201008-001








Erysipelothrix rhusiopathiae SY1027; str. Fujisawa
nanC TIGR4; Hungary19A-6; G54
nanB gamPNI0373
nanC THC8431/19A














S. iniae strain ISNO; ISET0901; SF1
S. pneumoniae strain NT_110_58
Clostridium perfringens strain JP55
S. pneumoniae 70585
S. intermedius B196
S. sp. VT 162
nanB CGSP14






Clostridium perfringens strain FORC_003
S. iniae strain YSFST01-82
nanB NT_110_58
S. agalactiae CNCTC 10/84
























S. pneumoniae nanB or nanC
Supplementary Figure 4. Yamaguchi et al.















































































































































Supplementary Figure 10. Yamaguchi et al.
Supplementary Figure 11. Yamaguchi et al.
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